Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q2 2021 Results - Earnings Call Transcript

Cryoport, Inc. (NASDAQ:CYRX) Q2 2021 Earnings Conference Call August 5, 2021 5:00 PM ET

Executives

Todd Fromer - Managing Partner-KCSA
Jerrell Shelton - Chairman, President and Chief Executive Officer
Robert Stefanovich - Chief Financial Officer, Treasurer and Corporate Secretary
Mark Sawicki - Chief Scientific Officer
Thomas Heinzen - Vice President-Corporate Development & Investor Relations

Analysts

Matt Andrews - Jefferies
Andrew D'Silva - B. Riley Securities
David Larsen - BTIG
Jacob Johnson - Stephens
Paul Knight - KeyBanc
Richard Baldry - Roth Capital

Operator

Good day, everyone and welcome to the Cryoport, Inc. Second Quarter 2021 Earnings Call. Today's conference is being recorded.

At this time, I would like to turn the conference over to Mr. Todd Fromer. please go ahead, sir.

Todd Fromer

Thank you, operator. Before we begin today, I would like to remind everyone that this conference call contains certain forward-looking statements. All statements that address our operating performance, events or developments that we expect or anticipate occurring in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and not on information currently available to our management team. Our management team believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements, because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events or otherwise, except as required by law.

In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to those described in Item 1A, risk factor and elsewhere